We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 494

Doctrine of bona fide purchaser for value without notice applies to patent rights
  • Borden Ladner Gervais LLP
  • Canada
  • February 6 2012

This case involves a dispute over who owned certain patent rights


Tesla’s patent pledge: is it enough?
  • Borden Ladner Gervais LLP
  • Canada
  • July 23 2014

Free use of patented technology? Caveat emptor. In a June 12, 2014 blog post titled, "All Our Patent Are Belong To You", Elon Musk, co-founder and


Doing Business in Canada, An Introduction to the Legal Aspects of Investing and Establishing a Business in Canada
  • Borden Ladner Gervais LLP
  • Canada
  • December 2 2016

This guide provides a practical overview of Canada's legal landscape to international businesses looking to establish operations in Canada or


Intellectual Property Weekly Abstracts Bulletin
  • Borden Ladner Gervais LLP
  • Canada
  • September 28 2016

In a patent infringement action, the defendant brought a motion relating to read-ins of portions of the Examinations for discovery. In particular, the


Canadian Patent Appeal Board Upholds Claims to Non-exemplified Humanized Antibodies
  • Borden Ladner Gervais LLP
  • Canada
  • August 9 2016

In a rare and long-awaited piece of good news for antibody patent applications in Canada, the Patent Appeal Board ("the Board") recently allowed


Motion for default judgment denied without affidavit evidence
  • Borden Ladner Gervais LLP
  • Canada
  • October 28 2013

The Plaintiffs brought a motion for default judgment after no Statement of Defence was filed and no response to the Request to Admit was provided. The


Court grants motion to reopen trial and admit new evidence
  • Borden Ladner Gervais LLP
  • Canada
  • April 27 2011

The Federal Court granted leave to reopen the trial and admit new evidence in a matter under reserve, in which no reasons or judgement have issued


Bill C-43 signals forthcoming changes to the Canadian Patent Act
  • Borden Ladner Gervais LLP
  • Canada
  • January 5 2015

On December 16, 2014, Bill C-43 received Royal Assent. The legislation includes amendments to the Canadian Patent Act that will eventually usher in


Patent is not found to be a selection patent, and thus was anticipated and obvious
  • Borden Ladner Gervais LLP
  • Canada
  • November 23 2015

The Federal Court has dismissed an application for prohibition to prevent the Minister of Health from issuing an NOC to Mylan for cinacalcet


Reply affidavits allowed when new documents introduced in responding evidence
  • Borden Ladner Gervais LLP
  • Canada
  • January 9 2014

In this case, there is a partial reversal of evidence. Apotex brought a motion for leave to file reply evidence. Allergan did not oppose parts of the